Navigation Links
Misconceptions About Bipolar Disorder Explained, From the Harvard Health Letter
Date:10/30/2007

lth Publications, the publishing division of Harvard Medical School, for $28 per year. Subscribe at http://www.health.harvard.edu/health or by calling 1-877-649-9457 (toll free).

Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.


'/>"/>
SOURCE Harvard Health Letter
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Autism: Symposium to Discuss Myths and Misconceptions
2. Misconceptions Put AIDS Patients In Tight-Spot
3. Misconceptions About Eating Eggs Busted
4. Misconceptions About Pet Owners Health Condition Revealed
5. Rajasthan Launches Programs to Overcome Misconceptions About Childbirth
6. People suffering from Alzheimer’s: can they take decisions about their treatment
7. Doctors In UK Have Reservations About NHS Plan
8. More about HIV
9. Teens listen to parents about smoking
10. Spreading knowledge to doctors about herbal medicine
11. A new discovery about Acetaminophen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...g to two studies presented today, a nonsurgical tr... diseased thoracic aorta// offered patients less r...ortality rates when compared to surgery. During su... paraplegia because the thoracic aorta is clamped,...
... of existing research confirms that health-care wo...eatment if they are exposed// to HIV on the job. ... research into so-called occupational postexposure... what should be done when health-care workers are ...
... Food and Drug Administration (FDA) and the Center...inding consumers of the dangers of drinking milk t... Raw milk potentially contains a wide variety of ...:H7, Listeria, Campylobacter and Brucella – that m...
...n, the compound that gives red pepper its heat, co...boratory study.// If the results can be replicate...ngthening of capsaicin in the weight management su... by Euromonitor International to be worth US$0.93b...
Other Medicine News:Health News:Nonsurgical Thoracic Aorta Repair Has Much Less Risk of Paralysis Than Surgery 2Health News:Health-Care Workers Exposed to HIV on Job Need Preventive Treatment 2Health News:Health-Care Workers Exposed to HIV on Job Need Preventive Treatment 3Health News:FDA and CDC Remind Consumers of the Dangers of Drinking Raw Milk 2Health News:Chilli Extract may Stop Fat Cell Growth 2
(Date:10/6/2008)...6 Weeks of Radiation Therapy -, Event: Watch Singl...sday, October 22, 2008, 3 - 4 p.m. by visiting ...Va., Oct. 6 / Questions raced through...st cancer in May. Would she have the,tumor removed...otherapy?, , To view the Multimedia News Release...
(Date:10/6/2008)...mpany,s Bioabsorbable Stent - Also,Slated for Pres...ire/ -- Data from multiple clinical trials of,the ...us Bio-engineered R,stent, will be presented next ...ics symposium, TCT 2008, in Washington, D.C., Rob...al Center in,Amsterdam will provide a Genous clini...
(Date:10/5/2008)...urnal of Medicine reaffirm,well-established effica...iHaler(R), RIDGEFIELD, Conn., and NEW YORK, Oct. ...ding Potential Long-term Impacts on Function with,...er(R) (tiotropium bromide,inhalation powder), sust...ars as measured by FEV(1) (p<0.001) versus placebo...
(Date:10/3/2008)...rstCall/ -- Amsterdam Molecular,Therapeutics (Euro...erapy,announced today that it intends to incorpor...on Application (MAA) for Glybera(R) for Lipoprotei...ng and potentially lethal,disease., The data obta...,patients in total) demonstrate that Glybera(R) is...
Breaking Medicine Technology:Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Medline Receives Force Majeure Notice From Hong Ray Enterprises 23248 1Medline Receives Force Majeure Notice From Hong Ray Enterprises 23248 2UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 1UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 2UNICEF Ambassador Clay Aiken Visits North West Somalia 23246 3AVMA Collections Highlights Disaster Preparedness 23244 1AVMA Collections Highlights Disaster Preparedness 23244 2GeneraMedix Inc Receives Approval for Epoprostenol for Injection 1 5 mg 6376 1GeneraMedix Inc Receives Approval for Epoprostenol for Injection 1 5 mg 6376 2
...gulatory News-Ipsen,(Paris:IPN) announced today th... study for its investigational 4-month formulation...nable blood levels,of triptorelin for a duration o...ecided not to perform the second,administration as...been observed throughout the trial. At the end of ...
...re/ -- GlaxoSmithKline,plc announced results from ...nvestigational non-peptide oral platelet growth,fa... this study,showed that PROMACTA at 50-75mg once d...ase in platelet counts and also,reduced bleeding i...topenic purpura (ITP). These patients had previous...
Other Medicine Technology:Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration 2Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 2Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 4Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 5Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 6
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: